Agilent | A - Cash And Equivalent

Stock Price
132.98
Daily Change
0.84 0.64%
Monthly
-6.96%
Yearly
-10.14%
Q1 Forecast
129.73

Agilent reported $1.79B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Abbott USD 7.51B 560M Sep/2025
Agilent USD 1.79B 254M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Exact Sciences USD 789.04M 131.94M Sep/2025
Henry Schein USD 136M 9M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 934M 179M Jun/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
IQVIA Holdings USD 1.81B 225M Sep/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Quidel USD 98.1M 53.6M Sep/2025
Repligen USD 748.75M 39.89M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 459.12M 91.9M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025